Research advance in primary ovarian Burkitt lymphoma
10.3760/cma.j.cn341190-20210323-00360
- VernacularTitle:原发性卵巢伯基特淋巴瘤研究进展
- Author:
Yingli LONG
1
;
Can SONG
Author Information
1. 青岛大学附属威海市立第二医院 威海市妇幼保健院妇女保健科，威海 264200
- Keywords:
Burkitt lymphoma;
Ovarian tumor;
Lymphoma, non Hodgkin;
Diagnosis, differential;
Review
- From:
Chinese Journal of Primary Medicine and Pharmacy
2022;29(8):1271-1275
- CountryChina
- Language:Chinese
-
Abstract:
Among all non-Hodgkin's lymphoma, primary ovarian Burkitt lymphoma (POBL) is a rare disease. Tumors can occur in one or both ovaries. The main symptoms of POBL are abdominal pain or a large abdominal mass. The differential diagnosis of POBL based on imaging characteristics and histopathological examination is the basis for further treatment of ovarian tumors from different sources. Although most patients with POBL have undergone surgical treatment after the discovery of ovarian masses, chemotherapy rather than surgery should be the main treatment method for them. Active chemotherapy combined with preventive central nervous system therapy leads to good prognosis. A variety of treatment schemes have been adopted, which greatly increase the survival rate of patients with POBL. In this review, we retrieved related literature and retrospectively reviewed the epidemiology, clinical manifestation, diagnosis and treatment of POBL. The purpose of this review is to draw clinicians' attention to the possibility of POBL when performing differential diagnosis of ovarian tumors.
